drugset / Trial / NCT01501513

A Safety Study of 3 Different Bowel Cleansing Preparations

NCT01501513

Phase 3 Completed 541 enrolled Braintree Laboratories
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to compare the safety, tolerance and efficacy of BLI800 (approved and investigational regimens) to an approved control preparation as bowel preparations prior to colonoscopy in adult patients, particularly including the elderly and those with renal and/or hepatic impairment.

Timeline

Start
2011-12
Primary completion
2013-03-04
Completion
2013-03-04

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI800 Unknown Oral
Comparator polyethylene glycol Other / unclassified Oral

Indications

No indication recorded.